Vyaderm Pharmaceuticals: The EVA Decision
In 2016, the new CEO of Vyaderm Pharmaceuticals launched an Economic Value Added (EVA) program to align the company with long-term shareholder value. The EVA program consists of three elements: EVA centers (business units), EVA drivers (operating practices that improve EVA results), and an EVA-based incentive program for eligible managers. Over the next two years, …